Renovion is dedicated to developing Arina-1 as the first FDA-approved therapy for patients who have received a lung transplant and expanding approval into other indications, including CF, COPD, asthma, VAP, ARDS and other diseases.
Board of Directors
RENOVION, INC. | UNITED STATES OF AMERICA
The server encountered an error.
GET IN TOUCH
Ask us a quick question
©COPYRIGHT RENOVION, INC.
DEVELOPED AND HOSTED BY CENTORI DIGITAL PTY(LTD)